Abstract
ObjectiveThe impact of pre-immunotherapy sarcopenia in patients with non-small cell lung cancer (NSCLC) receiving immune checkpoint inhibitors (ICIs) ......
小提示:本篇文献需要登录阅读全文,点击跳转登录